Evidence map›Paper›PMID 29132672›Full record

ReviewImmunology and allergy clinics of North America2018

Oral Tolerance Development and Maintenance.

Erik Wambre, David Jeong

Abstract readReview
In one paragraph

Review in Immunology and allergy clinics of North America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Pharmaceutics · 2026
    Review
  2. Article
  3. The Duodenal Microenvironment in Functional Dyspepsia.Journal of neurogastroenterology and motility · 2025
    Review
  4. Review
  5. Review
  6. Diversity of complementary diet and early food allergy risk.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2025
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Erik WambreBenaroya Research Institute at Virginia Mason, 1201 Ninth Avenue, Seattle, WA 98101, USA. Electronic address: ewambre@benaroyaresearch.org.
David JeongVirginia Mason Medical Center, 1201 Terry Avenue, Seattle, WA 98101, USA.

Funding

Induction and signature of pathogenic T cells in allergyR01AI108839 · NIAID · BENAROYA RESEARCH INST AT VIRGINIA MASON · PI WAMBRE, ERIK · 2014 to 2018
$2.1M
NIAID NIH HHS R01 AI108839
6 · The paper itself

Abstract

The gastrointestinal tract has an abundant mucosal immune system to develop and maintain oral tolerance. The oral route of administration takes advantage of the unique set of immune cells and pathways involved in the induction of oral tolerance. Food allergy results from a loss of oral tolerance toward ingested antigens. Oral immunotherapy is thought to initiate desensitization through interaction of an allergen with mucosal dendritic cells that initiate downstream immune system modulation through regulatory T cells and effector T cells.

Indexed as

Administration, OralAllergensAnimalsDendritic CellsDesensitization, ImmunologicFood HypersensitivityGastrointestinal MicrobiomeHumansImmune ToleranceImmunity, InnateT-Lymphocytes, RegulatoryT-Lymphocyte SubsetsAllergensCD4(+) T cellsDendritic cellsFood allergyImmune toleranceImmunotherapyMicrobiomeMucosal immunity

Identifiers

PMID29132672
PMCPMC5776674

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.